Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Judy M. Harrer"'
Autor:
Sara B. Berns, Genise Lalos, Susan Tross, Mary A. Hatch-Maillette, Donald A. Calsyn, Judy M. Harrer, Yong S. Song, Paul Crits-Christoph, Suzanne R. Doyle
Publikováno v:
Journal of Substance Abuse Treatment. 37:138-150
The effectiveness of a motivational and skills training HIV/AIDS group intervention designed for men in substance abuse treatment was evaluated. Men in methadone maintenance (n = 288) or outpatient psychosocial treatment (n = 302) completed assessmen
Autor:
Shou-Hua Li, Florence S. Coleman, Eugene Somoza, Daniel Lewis, R. Jeffrey Goldsmith, Roberta Kahn, Paul S. Horn, Maryam Afshar, Domenic A. Ciraulo, Ofra Sarid-Segal, Theresa Winhusen, Juris P. Mezinskis, Judy M. Harrer, Margaret A. Montgomery, Ahmed Elkashef, Sabuhi Osman
Publikováno v:
Drug and Alcohol Dependence. 91:205-212
Background Cocaine's increase of dopamine is strongly associated with its reinforcing properties and, thus, agents that reduce dopamine have received much attention as candidate cocaine-dependence treatments. The potential efficacy of reserpine, a do
Autor:
Timothy P. Dalton, Sarah L Freshwater, Willy A. Solis, Howard G. Shertzer, Judy M. Harrer, Lei He, Daniel W. Nebert, Matthew Z. Dieter
Publikováno v:
Biochemical Pharmacology. 63:1739-1754
Glutamate-cysteine ligase is a heterodimer comprising a modifier (GCLM) and a catalytic (GCLC) subunit. In mouse Hepa-1c1c7 hepatoma cell cultures, we found that tert-butylhydroquinone (tBHQ; 50 microM) induces the GCLM and GCLC mRNAs approximately 1
Autor:
Guoxiang Chu, Richard A. Walsh, Judy M. Harrer, Vivek J. Kadambi, Gerald W. Dorn, Evangelia G. Kranias, Wusheng Luo
Publikováno v:
Circulation Research. 81:485-492
Abstract Phospholamban, a prominent modulator of the sarcoplasmic reticulum (SR) Ca 2+ -ATPase activity and basal contractility in the mammalian heart, has been proposed to form pentamers in native SR membranes. However, the monomeric form of phospho
Publikováno v:
Circulation Research. 80:506-513
Abstract Phospholamban (PLB) is a protein associated with the Ca 2+ -ATPase of the sarcoplasmic reticulum (SR) in cardiac, slow-twitch skeletal, and smooth muscle. PLB inhibits the SR Ca 2+ -ATPase in cardiac muscle; this inhibition is relieved on ph
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 272:H57-H66
Phospholamban, the regulator of Ca(2+)-adenosinetriphosphatase (ATPase) activity in cardiac sarcoplasmic reticulum (SR), is an important determinant of basal myocardial performance. To determine whether phospholamban expression is developmentally reg
Autor:
Beata M. Wolska, Ingrid L. Grupp, Gunter Grupp, Jay Patrick Slack, Evangelia G. Kranias, Kobra Haghighi, Thomas Doetschman, Wusheng Luo, Judy M. Harrer, R. John Solaro, Donald G. Ferguson
Publikováno v:
Circulation Research. 78:839-847
Abstract Phospholamban ablation has been shown to result in significant increases in cardiac contractile parameters and loss of β-adrenergic stimulation. To determine whether partial reduction in phospholamban levels is also associated with enhancem
Publikováno v:
Molecular and Cellular Biochemistry. 146:13-21
Phospholamban (PLB) is a regulator of the sarcoplasmic reticulum Ca(2+)-ATPase (SERCA2) expressed in cardiac, slow-twitch skeletal, and smooth muscles. Phospholamban is not expressed in the sarcoplasmic reticulum of fast-twitch skeletal muscle, but i
Autor:
John J. Duffy, Ingrid L. Grupp, Judy M. Harrer, Thomas Doetschman, Wusheng Luo, Sathivel Ponniah, Gunter Grupp, Evangelia G. Kranias
Publikováno v:
Circulation Research. 75:401-409
Phospholamban is the regulator of the Ca(2+)-ATPase in cardiac sarcoplasmic reticulum (SR), and it has been suggested to be an important determinant in the inotropic responses of the heart to beta-adrenergic stimulation. To determine the role of phos
Autor:
Evangelia G. Kranias, Judy M. Harrer
Publikováno v:
Molecular and Cellular Biochemistry. 140:185-193
The native form of phospholamban is not known and it is presently under debate whether this protein exists as a monomer or an oligomer in cardiac sarcoplasmic reticulum. The currently accepted model for phospholamban is pentameric, based primarily on